PI 3-kinase, mTOR, protein synthesis and cancer

Trends in Molecular Medicine

Volumn 7, Issue 11, 2001, Pages 482-484

  Vogt, Peter K ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4E BINDING PROTEIN; BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; RAPAMYCIN; S6 KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; CANCER; CARCINOGENESIS; ENZYME ANALYSIS; ENZYME MECHANISM; GROWTH REGULATION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RAT; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0034764605     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(01)02161-X     Document Type: Review

References (20)

1. Oncogenic kinase signalling
2. TOR, a central controller of cell growth
3. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k
4. eIF4 initiation factors: Effectors of mRNA recruitment to ribosomes and regulators of translation
5. PIK3CA is implicated as an oncogene in ovarian cancer
6. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
7. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells
8. Isolation of DNA sequences amplifed at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer
9. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines
10. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas
11. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas
12. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA
13. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
14. eIF4E expression in tumors: Its possible role in progression of malignancies
15. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy
16. +/- mice
17. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
18. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt
19. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap
20. Constitutive activation of S6 kinase by deletion of amino-terminal autoinhibitory and rapamycin sensitivity domains